Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3205 EUR | +1.10% | +9.57% | -74.76% |
09/07 | Redhill Biopharma Ltd. Terminates License Agreement for Aemcolo | CI |
06/06 | RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board | CI |
Chart calendar RedHill Biopharma Ltd.
Upcoming events on RedHill Biopharma Ltd.
Past events on RedHill Biopharma Ltd.
07/05/2024 08:30 pm | Aegis Capital Virtual Conference |
08/04/2024 06:53 pm | Q4 2023 Earnings Release |
17/08/2023 04:30 pm | Q2 2023 Earnings Release |
12/06/2023 05:30 pm | Q1 2023 Earnings Release |
04/05/2023 08:30 pm | Aegis Capital Corp Virtual Conference |
28/04/2023 04:30 pm | Q4 2022 Earnings Release |
29/11/2022 06:30 pm | Q3 2022 Earnings Release |
21/11/2022 | International Conference on Microbiology & Infectious Diseases |
21/10/2022 | American College of Gastroenterology Scientific Meeting - Poster No - A089 |
21/10/2022 | American College of Gastroenterology Scientific Meeting - Poster No - A090 |
21/10/2022 | American College of Gastroenterology Scientific Meeting - Poster No - A0683 |
17/08/2022 | Talicia® -World Gastro Congress |
07/08/2022 | International Conference on Emerging Infectious Diseases |
13/07/2022 | ARDS Drug Development Summit |
23/06/2022 06:00 pm | Q1 2022 Earnings Call |
23/06/2022 04:30 pm | Q1 2022 Earnings Release |
23/05/2022 | H.C. Wainwright Global Life Sciences Investment Conference |
21/05/2022 | Digestive Diseases Week Conference - Poster Number: Tu1078 |
21/05/2022 | Digestive Diseases Week Conference - poster number: Tu1077 |
12/05/2022 05:30 pm | Annual General Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 6,29 6,88 -8.55% | 64,4 68,1 -5.54% | 85,8 87,9 -2.44% | 61,8 68,0 -9.12% |
EBITDA Million USD | Released Forecast Spread | -42,2 -40,2 -5.05% | -54,9 -48,0 -14.46% | -69,0 -66,0 -4.56% | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -43,2 -42,1 -2.5% | -63,7 -49,9 -27.6% | -81,1 -78,1 -3.92% | -42,8 -29,7 -44.26% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -42,3 -41,3 -2.37% | -76,2 -65,3 -16.73% | -97,7 -95,0 -2.93% | -71,7 -41,1 -74.38% |
Net income Million USD | Released Forecast Spread | -42,3 -41,3 -2.37% | -76,2 -65,3 -16.73% | -97,7 -95,0 -2.93% | -71,7 -41,1 -74.38% |
EPS USD | Released Forecast Spread | -56,0 -35,3 -58.73% | -84,0 -46,6 -80.41% | -84,0 -39,5 -112.43% | -1,20 -2,80 57.14% |
Announcement Date | 04/03/20 | 18/03/21 | 17/03/22 | 28/04/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 22,1 24,1 -8.37% | 18,2 23,6 -22.73% | 18,3 21,5 -14.68% | 17,6 18,5 -5.12% | 12,8 18,1 -29.29% |
EBITDA Million USD | Released Forecast Spread | -18,4 -15,4 -19.32% | -10,4 -14,4 27.81% | |||
EBIT Million USD | Released Forecast Spread | -20,7 -17,6 -17.5% | -13,2 -15,1 12.33% | -9,16 -6,89 -32.93% | -7,11 -4,20 -69.24% | -9,95 0,30 -3416% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,4 -22,0 -10.8% | -17,1 -17,6 2.63% | -11,7 -10,6 -10.4% | -35,7 -7,50 -376.01% | -3,73 -1,40 -166.36% |
Net income Million USD | Released Forecast Spread | -24,4 -22,0 -10.8% | -17,1 -17,6 2.63% | -11,7 -10,6 -10.4% | -35,7 -7,50 -376.01% | -3,73 -1,40 -166.36% |
EPS USD | Released Forecast Spread | -20,0 -8,34 -139.73% | -1,20 -1,20 0% | -0,80 -0,60 -33.33% | -2,40 -0,40 -500% | 0,00 0,00 - |
Announcement Date | 17/03/22 | 23/06/22 | 07/11/22 | 29/11/22 | 28/04/23 |
23/07/2024 11:30 am | BIOGAIA AB: Q2 2024 Earnings Release |
24/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 10:30 am | UCB: Q2 2024 Earnings Release |
26/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release |
30/07/2024 | BIOTEST AG: Q2 2024 Earnings Release |
30/07/2024 04:30 pm | INCYTE CORPORATION: Q2 2024 Earnings Release |
31/07/2024 | VERICEL CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for RedHill Biopharma Ltd.
Today | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
11/07/2024 04:00 pm | KALVISTA PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
11/07/2024 11:30 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
23/05/2024 03:13 pm | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
16/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
14/05/2024 09:05 pm | GRIFOLS, S.A.: Q1 2024 Earnings Release |
14/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RDHL Stock
- 2RH0 Stock
- Calendar RedHill Biopharma Ltd.